Syndax Pharmaceuticals, Inc. — Cash Flow Charts
44 quarters of history · ending 2025-12-31 · SEC EDGAR
Operating Cash Flow↓-13.9% -$12M
$-95M
Free Cash Flow
$-14K
Investing Cash Flow
$82M
Financing Cash Flow↓-98.3% -$342M
$6M
Capex
$14K
Stock-Based Comp↓-8.5% -$1M
$11M